SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹23 Cr | ₹-5.96 Cr | ₹11 Cr | ₹16 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹-5.96 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹16 Cr |
| Mar2017 | ₹14 Cr |
How is Cash Flow from Operating Activities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | Positive | |
| Mar2024 | ₹-5.96 Cr | Negative | |
| Mar2023 | ₹11 Cr | -35.52 | |
| Mar2022 | ₹16 Cr | 17.98 | |
| Mar2017 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,316.9 Cr | -1.6% | -3.9% | -28.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.6% |
-3.9% |
-28.7% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses